Browse by author
Lookup NU author(s): Dr Alison Yarnall,
Professor David Burn
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Progressive supranuclear palsy (PSP) is a tauopathy that generally results in a hypokinetic disorder. Treatment is largely symptomatic, with some small studies indicating a benefit with dopaminergic therapy. Myoclonus is a hyperkinetic disorder that can be seen as part of later stage Parkinson's disease and in multiple system atrophy, but is rarely seen in PSP. Here we report a case of myoclonus precipitated by amantadine in a patient with PSP.
Author(s): Yarnall AJ, Burn DJ
Publication type: Article
Publication status: Published
Journal: Age and Ageing
Print publication date: 15/03/2012
ISSN (print): 0002-0729
ISSN (electronic): 1468-2834
Publisher: Oxford University Press
Altmetrics provided by Altmetric